This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Global Pharmaceutical Regulatory Affairs Summit
21-23 October 2025
Hotel Palace BerlinBerlin, DE
Menu

Hans van Bruggen
Chief Scientific Officer at Celegence
Speaker

Profile

Hans van Bruggen is Chief Scientific Officer at Celegence. He has an MSc in Pharmaceutical Medicine from the University of Surrey (UK) and has worked within, or for, the pharmaceutical industry for more than 40 years in Global or European Headquarters. He has gained a wealth of experience and a comprehensive view on what information is needed to evaluate the benefit/risk ratio of drugs for patients (and healthy volunteers). Using that scientific background, he approaches interdisciplinary and international processes related to data, documents and dossiers.

Agenda Sessions

  • Facilitating the Digital Transformation of Module 3 to PQ/CMC, IDMP and ICH M4Q R2

    , 09:40
    View Session

At this event

Prev
Next
Maren von Fritschen
Head Regulatory Policy EU
Moderna

See Hans at Global Pharmaceutical Regulatory Affairs Summit